HANGER, INC. Stock: price and directors' dealings · United States · SEC (Form 4)

About HANGER, INC.

Hanger, Inc. (ticker HGR) is a U.S.-listed company traded in the United States on the NYSE/NASDAQ, operating in the orthotic and prosthetic (O&P) care market. Its core business is to design, fabricate, distribute, and deliver medical solutions for patients dealing with limb loss, limb difference, and other mobility-related or orthopedic support needs. The company is best known for Hanger Clinic, its patient-care network, and for an integrated O&P ecosystem that connects clinical care, product development, fabrication, distribution, and patient support. ([news.hanger.com](https://news.hanger.com/about-us/?utm_source=openai)) Hanger traces its origins back to 1861, when James Edward Hanger founded the business after losing a leg during the American Civil War and developing an early prosthetic solution. That origin gives the company a uniquely long history in the mobility-care field. Over time, Hanger evolved from an artisanal prosthetics business into a scaled clinical and manufacturing platform. The company is headquartered in Austin, Texas, reinforcing its base in the United States and its access to healthcare and technology talent. ([news.hanger.com](https://news.hanger.com/about-us/?utm_source=openai)) Operationally, Hanger is organized into two main segments: Patient Care and Products & Services. Patient Care includes the Hanger Clinic network, which provides individualized orthotic and prosthetic treatment and custom patient solutions. Products & Services covers manufacturing and distribution of O&P components, orthoses, prostheses, pediatric solutions, and related devices. Management emphasizes an outcomes-based model, meaning the company focuses on measurable clinical results, functional improvement, and long-term patient value rather than simply product volume. ([news.hanger.com](https://news.hanger.com/about-us/?utm_source=openai)) From a competitive standpoint, Hanger is one of the better-known scale players in the U.S. O&P market. Its strengths include national reach, an integrated care-and-products model, and continued investment in clinical research and education. The company also highlights its professional training infrastructure, including a national O&P residency program that has trained more than 950 residents since 1996, as well as an institute dedicated to research and evidence-based care. ([corporate.hanger.com](https://corporate.hanger.com/news/2026/hanger-institute-for-clinical-research-and-education-releases-2025-2026-annual-report-highlighting-landmark-advances-in-orthotic-and-prosthetic-care/?utm_source=openai)) Geographically, Hanger’s footprint is overwhelmingly domestic, with more than 925 patient-care locations across the country according to recent company communications, plus U.S.-based manufacturing and distribution operations. A notable operational development was the 2024 opening of a West Coast distribution center in Fresno, California, which supports nationwide fulfillment for O&P products. ([corporate.hanger.com](https://corporate.hanger.com/news/2025/hanger-clinic-enters-clinical-services-agreement-for-orthotic-and-prosthetic-care-with-premier-inc/?utm_source=openai)) Recent strategic and product news underscores the company’s innovation focus. In 2025, Hanger announced an impending acquisition of Point Designs, a firm specializing in partial-hand prosthetics and additive manufacturing. The company’s portfolio also saw new product activity through Surestep’s 3D-printed cranial remolding orthosis launch. In 2026, Hanger Institute released its 2025–2026 annual report, highlighting progress in clinical research, AI-supported decision-making, and evidence-based O&P care. Taken together, these developments point to a company positioning itself as a clinically differentiated leader in a specialized healthcare niche. ([news.hanger.com](https://news.hanger.com/press-releases/press-release-details/2025/Hanger-Announces-Impending-Acquisition-of-Point-Designs/default.aspx?utm_source=openai))